HSBC Holdings’s Mustang Bio MBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-145
Closed -$38.7K 2888
2022
Q4
$38.7K Sell
145
-3
-2% -$1.02K ﹤0.01% 2985
2022
Q3
$54K Sell
148
-13
-8% -$6.02K ﹤0.01% 2808
2022
Q2
$70K Hold
161
﹤0.01% 3098
2022
Q1
$122K Hold
161
﹤0.01% 3091
2021
Q4
$203K Buy
161
+81
+101% +$131K ﹤0.01% 3032
2021
Q3
$156K Buy
80
+65
+433% +$140K ﹤0.01% 2829
2021
Q2
$38K Buy
+15
New +$36.8K ﹤0.01% 2893

Other funds holding MBIO

HSBC Holdings's MBIO Position: Q1 2023 in Review

HSBC Holdings sold out of Mustang Bio (MBIO) in Q1 2023, closing a stake of 145 shares — an estimated $38.7K sold.

HSBC Holdings first reported a position in MBIO in Q2 2021 and held it in 7 quarters. The position peaked at $203K in Q4 2021. 48 funds tracked by Wall St. Rank hold MBIO as of Q1 2023.

  • HSBC Holdings reported no remaining Mustang Bio position as of Q1 2023 after selling out during the quarter.
  • HSBC Holdings sold 145 Mustang Bio shares in Q1 2023, an estimated $38.7K.
  • HSBC Holdings first reported a position in Mustang Bio in Q2 2021 and held it in 7 quarters.
  • HSBC Holdings's Mustang Bio position peaked at $203K in Q4 2021.
  • 48 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2023.

Based on HSBC Holdings's 13F filing for Q1 2023, filed 15 May 2023.